ChromaCode Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 65

Employees

  • Latest Deal Type
  • Series AA

  • Latest Deal Amount
  • $3.85M

  • Investors
  • 13

ChromaCode General Information

Description

Developer of a molecular diagnostics technology designed to connect patients to the treatment through smarter, accessible diagnostics. The company's technology blends signal processing and tailored chemistry to allow for multiplexed, low-cost chemistry that integrates into existing laboratory workflows, enabling laboratories to carry out testing of multiple targets in a single sample on common, existing quantitative polymerase chain reaction instrumentation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2292 Faraday Avenue
  • Suite 110
  • Carlsbad, CA 92008
  • United States
+1 (442)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 2292 Faraday Avenue
  • Suite 110
  • Carlsbad, CA 92008
  • United States
+1 (442)

ChromaCode Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ChromaCode Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series AA) 30-Jan-2025 $3.85M Completed Generating Revenue
5. Later Stage VC (Series D) 27-Feb-2023 Completed Generating Revenue
4. Grant 16-Mar-2021 Completed Generating Revenue
3. Later Stage VC (Series C) 03-Dec-2020 Completed Generating Revenue
2. Later Stage VC (Series B) 25-Apr-2017 $12M $14.2M Completed Generating Revenue
1. Early Stage VC (Series A1) 13-Aug-2015 $2.2M $2.2M Completed Generating Revenue
To view ChromaCode’s complete valuation and funding history, request access »

ChromaCode Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D-2
Series D-1
Series C
Series B 17,251,462 $0.000100 $0.06 $0.7 $0.7 $0.7 9.53%
Series A1 10,805,082 $0.000100 $0.02 $0.24 $0.24 $0.24 5.97%
To view ChromaCode’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

ChromaCode Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a molecular diagnostics technology designed to connect patients to the treatment through smarter, accessibl
Diagnostic Equipment
Carlsbad, CA
65 As of 2024

New York, NY
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ChromaCode Competitors (8)

One of ChromaCode’s 8 competitors is Medidata Solutions, a Formerly VC-backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Medidata Solutions Formerly VC-backed New York, NY
Pleno Venture Capital-Backed San Diego, CA
Biofidelity Venture Capital-Backed Cambridge, United Kingdom
MedNet (Healthcare Technology Systems) Formerly VC-backed Minnetonka, MN
Medrio Venture Capital-Backed San Francisco, CA
You’re viewing 5 of 8 competitors. Get the full list »

ChromaCode Patents

ChromaCode Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250361566-A1 Tumor-informed digital pcr profiling technology for monitoring circulating tumor dna Pending 22-May-2024
US-20240392359-A1 Detection of donor dna in transplant recipient bio-sample Pending 11-May-2023
US-20250263781-A1 Methods, systems and compositions for detection of multiple analytes Pending 15-Jul-2022
WO-2024015999-A1 Methods, systems and compositions for detection of multiple analytes Inactive 15-Jul-2022
US-20260110017-A1 Systems, methods, and compositions for digital drop-off assays Pending 15-Jul-2022 C12Q1/682
To view ChromaCode’s complete patent history, request access »

ChromaCode Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ChromaCode Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Global Brain Venture Capital Minority
Shimadzu (Japan) PE-Backed Company Minority
Vensana Capital Venture Capital Minority
XPRIZE Other
Adjuvant Capital Impact Investing Minority
You’re viewing 5 of 13 investors. Get the full list »

ChromaCode FAQs

  • When was ChromaCode founded?

    ChromaCode was founded in 2012.

  • Where is ChromaCode headquartered?

    ChromaCode is headquartered in Carlsbad, CA.

  • What is the size of ChromaCode?

    ChromaCode has 65 total employees.

  • What industry is ChromaCode in?

    ChromaCode’s primary industry is Diagnostic Equipment.

  • Is ChromaCode a private or public company?

    ChromaCode is a Private company.

  • What is ChromaCode’s current revenue?

    The current revenue for ChromaCode is .

  • How much funding has ChromaCode raised over time?

    ChromaCode has raised $101M.

  • Who are ChromaCode’s investors?

    Global Brain, Shimadzu (Japan), Vensana Capital, XPRIZE, and Adjuvant Capital are 5 of 13 investors who have invested in ChromaCode.

  • Who are ChromaCode’s competitors?

    Medidata Solutions, Pleno, Biofidelity, MedNet (Healthcare Technology Systems), and Medrio are some of the 8 competitors of ChromaCode.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process